Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab

2015594 citationsJournal Articlegreen Open Access

Authors

clinicaltrials.gov Identifier: NCT00553358.

Good health and well-being

Published in: JAMA Oncology

Volume 1, Issue 4, pp. 448-448

Field-Weighted Citation Impact: 24.89